X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Strides Arcolab with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs TEVA PHARMA (Israel) - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES SHASUN LTD   TEVA PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
TEVA PHARMA
Dec-13
STRIDES SHASUN LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2752,665-   
Low Rs9182,315-   
Sales per share (Unadj.) Rs389.61,529.5-  
Earnings per share (Unadj.) Rs28.095.5-  
Cash flow per share (Unadj.) Rs48.9219.2-  
Dividends per share (Unadj.) Rs4.5083.64-  
Dividend yield (eoy) %0.43.4 12.2%  
Book value per share (Unadj.) Rs303.11,699.0-  
Shares outstanding (eoy) m89.42848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.6 172.9%   
Avg P/E ratio x39.226.1 150.4%  
P/CF ratio (eoy) x22.411.4 197.4%  
Price / Book Value ratio x3.61.5 246.8%  
Dividend payout %16.187.5 18.4%   
Avg Mkt Cap Rs m98,0362,111,647 4.6%   
No. of employees `0005.844.9 12.9%   
Total wages/salary Rs m5,8810-   
Avg. sales/employee Rs Th6,005.928,858.6 20.8%   
Avg. wages/employee Rs Th1,014.00-   
Avg. net profit/employee Rs Th431.21,802.8 23.9%   
INCOME DATA
Net Sales Rs m34,8341,297,049 2.7%  
Other income Rs m1,6860-   
Total revenues Rs m36,5201,297,049 2.8%   
Gross profit Rs m6,428355,198 1.8%  
Depreciation Rs m1,872104,842 1.8%   
Interest Rs m2,26925,476 8.9%   
Profit before tax Rs m3,973224,880 1.8%   
Minority Interest Rs m01,022 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,006-147,621 0.7%   
Tax Rs m470-2,746 -17.1%   
Profit after tax Rs m2,50181,026 3.1%  
Gross profit margin %18.527.4 67.4%  
Effective tax rate %11.8-1.2 -968.9%   
Net profit margin %7.26.2 114.9%  
BALANCE SHEET DATA
Current assets Rs m38,165876,022 4.4%   
Current liabilities Rs m30,402763,965 4.0%   
Net working cap to sales %22.38.6 258.0%  
Current ratio x1.31.1 109.5%  
Inventory Days Days7791 85.2%  
Debtors Days Days10496 108.9%  
Net fixed assets Rs m37,639423,645 8.9%   
Share capital Rs m8943,193 28.0%   
"Free" reserves Rs m26,2100-   
Net worth Rs m27,1051,440,775 1.9%   
Long term debt Rs m16,377663,210 2.5%   
Total assets Rs m81,1682,964,172 2.7%  
Interest coverage x2.89.8 28.0%   
Debt to equity ratio x0.60.5 131.3%  
Sales to assets ratio x0.40.4 98.1%   
Return on assets %5.93.6 163.6%  
Return on equity %9.25.6 164.1%  
Return on capital %12.14.9 244.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m9,3890-   
CASH FLOW
From Operations Rs m2,881206,682 1.4%  
From Investments Rs m-7,051-73,236 9.6%  
From Financial Activity Rs m3,382-247,930 -1.4%  
Net Cashflow Rs m-788-114,483 0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare STRIDES SHASUN LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare STRIDES SHASUN LTD With: SHASUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  PANACEA BIOTECH  TTK HEALTHCARE  



Today's Market

Of Sensex Touching New Highs, Takeaways from Acquisition of HPCL and Top Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,798 yesterday. Considering a span of one year, the benchmark index has delivered a 32% return.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jan 23, 2018 09:29 AM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS